| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.085 | 0.04 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.04 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.33 | 0.04 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |